Skin denervation in type 2 diabetes: Correlations with diabetic duration and functional impairments

Brain

Volumn 127, Issue 7, 2004, Pages 1593-1605

  Shun, Chia Tung ^a,b   Chang, Yang Chyuan ^a   Wu, Huey Peir ^a   Hsieh, Song Chou ^a   Lin, Whei Min ^b   Lin, Yea Hui ^a   Tai, Tong Yuan ^a   Hsieh, Sung Tsang ^a,b  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Diabetic neuropathy; Epidermal nerves; Nerve conduction studies; Quantitative sensory testing; Skin biopsy; Ubiquitin

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C;

ACTION POTENTIAL; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DENERVATION; DIABETIC NEUROPATHY; DISEASE DURATION; FEMALE; FUNCTIONAL DISEASE; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN TISSUE; LEG; MALE; NERVE CONDUCTION; NERVE FIBER; NEUROPHYSIOLOGY; NON INSULIN DEPENDENT DIABETES MELLITUS; PERCEPTIVE THRESHOLD; PERONEUS NERVE; PRIORITY JOURNAL; SENSORY NEUROPATHY; SKIN BIOPSY; SKIN NERVE; SURAL NERVE; SYMPTOMATOLOGY;

CASE-CONTROL STUDIES; CHRONIC DISEASE; COLD; DIABETES MELLITUS, TYPE 2; DIABETIC NEUROPATHIES; EPIDERMIS; FEMALE; HEAT; HUMANS; IMMUNOHISTOCHEMISTRY; LEG; LINEAR MODELS; MALE; MIDDLE AGED; NERVE DEGENERATION; NERVE FIBERS; NEURAL CONDUCTION; SENSORY THRESHOLDS; TIME FACTORS; UBIQUITIN THIOLESTERASE; VIBRATION;

EID: 3142626553     PISSN: 00068950     EISSN: None     Source Type: Journal    
DOI: 10.1093/brain/awh180     Document Type: Article

References (64)

1. Adler AI, Boyko EJ, Ahroni JH, Smith DG. Lower-extremity amputation in diabetes. The independent effects of peripheral vascular disease, sensory neuropathy, and foot ulcers. Diabetes Care 1999; 22: 1029-35.
2. Albers JW, Kenny DJ, Brown M, Greene D, Cleary PA, Lachin JM, et al. Effect of intensive diabetes treatment on nerve conduction in the Diabetes Control and Complications Trial. Ann Neurol 1995; 38: 869-80.
3. Albers JW, Brown MB, Sima AA, Greene DA. Nerve conduction measures in mild diabetic neuropathy in the Early Diabetes Intervention Trial: the effects of age, sex, type of diabetes, disease duration, and anthropometric factors. Tolrestat Study Group for the Early Diabetes Intervention Trial. Neurology 1996; 46: 85-91.
4. American Diabetes Association. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1997; 20: 1183-97.
5. Anand P, Terenghi G, Warner G, Kopelman P, Williams-Chestnut RE, Sinicropi DV. The role of endogenous nerve growth factor in human diabetic neuropathy. Nature Med 1996; 2: 703-7.
6. Bickel A, Butz M, Schmelz M, Handwerker HO, Neundorfer B. Density of sympathetic axons in sural nerve biopsies of neuropathy patients is related to painfulness. Pain 2000; 84: 413-9.
7. Calcutt NA, Allendoerfer KL, Mizisin AP, Middlemas A, Freshwater JD, Burgers M, et al. Therapeutic efficacy of sonic hedgehog protein in experimental diabetic neuropathy. J Clin Invest 2003; 111: 507-14.
8. Chiang HY, Huang IT, Chen WP, Chien HF, Shun CT, Chang YC, et al. Regional difference in epidermal thinning after skin denervation. Exp Neurol 1998; 154: 137-45.
9. Chien HF, Tseng TJ, Lin WM, Yang CC, Chang YC, Chen RC, et al. Quantitative pathology of cutaneous nerve terminal degeneration in the human skin. Acta Neuropathol (Berl) 2001; 102: 455-61.
10. Clapham DE. TRP channels as cellular sensors. Nature 2003; 426: 517-24.
11. Consensus Development Conference. Proceedings of a consensus development conference on standardized measures in diabetic neuropathy. Electrodiagnostic measures. Neurology 1992; 42: 1827-9.
12. Cornblath DR, Chaudhry V, Carter K, Lee D, Seysedadr M, Miernicki M, et al. Total neuropathy score: validation and reliability study. Neurology 1999; 53: 1660-4.
13. Diemel LT, Cai F, Anand P, Warner G, Kopelman PG, Fernyhough P, et al. Increased nerve growth factor mRNA in lateral calf skin biopsies from diabetic patients. Diabetes Med 1999; 16: 113-8.
14. Dyck PJ, Sherman WR, Hallcher LM, Service FJ, O'Brien PC, Grina LA, et al. Human diabetic endoneurial sorbitol, fructose, and myo-inositol related to sural nerve morphometry. Ann Neurol 1980; 8: 590-6.
15. Dyck PJ, Davies JL, Wilson DM, Service FJ, Melton LJ, 3rd, O'Brien PC. Risk factors for severity of diabetic polyneuropathy: intensive longitudinal assessment of the Rochester Diabetic Neuropathy Study cohort. Diabetes Care 1999; 22: 1479-86.
16. Dyck PJ, Dyck PJ, Larson TS, O'Brien PC, Velosa JA. Patterns of quantitative sensation testing of hypoesthesia and hyperalgesia are predictive of diabetic polyneuropathy: a study of three cohorts. Nerve growth factor study group. Diabetes Care 2000; 23: 510-17.
17. Eaton SE, Harris ND, Ibrahim S, Patel KA, Selmi F, Radatz M, et al. Increased sural nerve epineufial blood flow in human subjects with painful diabetic neuropathy. Diabetologia 2003; 46: 934-9.
18. Facer P, Mathur R, Pandya SS, Ladiwala U, Singhal BS, Anand P. Correlation of quantitative tests of nerve and target organ dysfunction with skin immunohistology in leprosy. Brain 1998; 121: 2239-47.
19. Feldman EL. Oxidative stress and diabetic neuropathy: a new understanding of an old problem. J Clin Invest 2003; 111: 431-33.
20. Griffin JW, McArthur JC, Polydefkis M. Assessment of cutaneous innervation by skin biopsies. Curr Opin Neurol 2001; 14: 655-9.
21. Hilliges M, Wang L, Johansson O. Ultrastructural evidence for nerve fibers within all vital layers of the human epidermis. J Invest Dermatol 1995; 104: 134-7.
22. Hirai A, Yasuda H, Joko M, Maeda T, Kikkawa R. Evaluation of diabetic neuropathy through the quantitation of cutaneous nerves. J Neurol Sci 2000; 172: 55-62.
23. Hsieh ST, Choi S, Lin WM, Chang YC, McArthur JC, Griffin JW. Epidermal denervation and its effects on keratinocytes and Langerhans cells. J Neurocytol 1996; 25: 513-24.
24. Hsieh ST, Lin WM. Modulation of keratinocyte proliferation by skin innervation. J Invest Dermatol 1999; 113: 579-86.
25. Hsieh ST, Chiang HY, Lin WM. Pathology of nerve terminal degeneration in the skin. J Neuropathol Exp Neurol 2000; 59: 297-307.
26. Karanth SS, Springall DR, Kuhn DM, Levene MM, Polak JM. An immunocytochemical study of cutaneous innervation and the distribution of neuropeptides and protein gene product 9.5 in man and commonly employed laboratory animals. Am J Anat 1991; 191: 369-83.
27. Kennedy WR, Said G. Sensory nerves in skin: answers about painful feet? Neurology 1999; 53: 1614-5.
28. Kennedy WR, Wendelschafer-Crabb G. The innervation of human epidermis. J Neurol Sci 1993; 115: 184-90.
29. Kennedy WR, Wendelschafer-Crabb G. Utility of skin biopsy in diabetic neuropathy. Semin Neurol 1996; 16: 163-71.
30. Kennedy WR, Wendelschafer-Crabb G. Utility of the skin biopsy method in studies of diabetic neuropathy. Electroencephalogr Clin Neurophysiol Suppl 1999; 50: 553-9.
31. Kennedy WR, Wendelschafer-Crabb G, Johnson T. Quantitation of epidermal nerves in diabetic neuropathy. Neurology 1996; 47: 1042-8.
32. Ko MH, Chen WP, Hsieh ST. Neuropathology of skin denervation in acrylamide-induced neuropathy. Neurobiol Dis 2002; 11: 155-65.
33. Lauria G, Morbin M, Lombardi R, Borgna M, Mazzoleni G, Sghirlanzoni A, et al. Axonal swellings predict the degeneration of epidermal nerve fibers in painful neuropathies. Neurology 2003; 61: 631-6.
34. Lentz SI, Knudson CM, Korsmeyer SJ, Snider WD. Neurotrophins support the development of diverse sensory axon morphologies. J Neurosci 1999; 19: 1038-48.
35. Levy DM, Karanth SS, Springall DR, Polak JM. Depletion of cutaneous nerves and neuropeptides in diabetes mellitus: an immunocytochemical study. Diabetologia 1989; 32: 427-33.
36. Lin YH, Huang MH, Chang YC, Tai TY, Chen WH, Yang CC, et al. Quantitative sensory testing: normative values and its application in diabetic neuropathy. Acta Neurol Taiwan 1998; 7: 176-84.
37. Llewelyn JG, Gilbey SG, Thomas PK, King RH, Muddle JR, Watkins PJ. Sural nerve morphometry in diabetic autonomic and painful sensory neuropathy. A clinicopathological study. Brain 1991; 114: 867-92.
38. Malik RA, Veves A, Walker D, Siddique I, Lye RH, Schady W, et al. Sural nerve fibre pathology in diabetic patients with mild neuropathy: relationship to pain, quantitative sensory testing and peripheral nerve electrophysiology. Acta Neuropathol (Berl) 2001; 101: 367-74.
39. McArthur JC, Stocks EA, Hauer P, Cornblath DR, Griffin JW. Epidermal nerve fiber density: normative reference range and diagnostic efficiency. Arch Neurol 1998; 55: 1513-20.
40. McCarthy B, Hsieh ST, Stocks EA, Hauer P, Macko C, Cornblath DR, et al. Cutaneous innervation in sensory neuropathies: evaluation by skin biopsy. Neurology 1995; 45: 1848-55.
41. McNeely MJ, Boyko EJ, Ahroni JH, Stensel VL, Reiber GE, Smith DG, et al. The independent contributions of diabetic neuropathy and vasculopathy in foot ulceration. How great are the risks? Diabetes Care 1995; 18: 216-9.
42. Pan CL, Lin YH, Lin WM, Tai TY, Hsieh ST. Degeneration of nociceptive nerve terminals in human peripheral neuropathy. Neuroreport 2001a; 12: 787-92.
43. Pan CL, Yuki N, Koga M, Chiang MC, Hsieh ST. Acute sensory ataxic neuropathy associated with monospecific anti-GDlb IgG antibody. Neurology 2001b; 57: 1316-8.
44. Pan CL, Tseng TJ, Lin YH, Chiang MC, Lin WM, Hsieh ST. Cutaneous innervation in Guillain-Barré syndrome: pathology and clinical correlations. Brain 2003; 126: 386-97.
45. Periquet MI, Novak V, Collins MP, Nagaraja HN, Erdem S, Nash SM, et al. Painful sensory neuropathy: prospective evaluation using skin biopsy. Neurology 1999; 53: 1641-7.
46. Perkins BA, Greene DA, Bril V. Glycemic control is related to the morphological severity of diabetic sensorimotor polyneuropathy. Diabetes Care 2001; 24: 748-52.
47. Polydefkis M, Hauer P, Griffin JW, McArthur JC. Skin biopsy as a tool to assess distal small fiber innervation in diabetic neuropathy. Diabetes Technol Ther 2001; 3: 23-8.
48. Polydefkis M, Griffin JW, McArthur J. New insights into diabetic polyneuropathy. J Am Med Assoc 2003; 290: 1371-6.
49. Properzi G, Francavilla S, Poccia G, Aloisi P, Gu XH, Terenghi G, et al. Early increase precedes a depletion of VIP and PGP-9.5 in the skin of insulin-dependent diabetics-correlation between quantitative immunohistochemistry and clinical assessment of peripheral neuropathy. J Pathol 1993; 169: 269-77.
50. Rajan B, Polydefkis M, Hauer P, Griffin JW, McArthur JC. Epidermal reinnervation after intracutaneous axotomy in man. J Comp Neurol 2003; 457: 24-36.
51. Said G, Lacroix C, Lozeron P, Ropert A, Plante V, Adams D. Inflammatory vasculopathy in multifocal diabetic neuropathy. Brain 2003; 126: 376-85.
52. Sands ML, Shetterly SM, Franklin GM, Hamman RF. Incidence of distal symmetric (sensory) neuropathy in NIDDM. The San Luis Valley Diabetes Study. Diabetes Care 1997; 20: 322-9.
53. Singleton JR, Smith AG, Bromberg MB. Increased prevalence of impaired glucose tolerance in patients with painful sensory neuropathy. Diabetes Care 2001; 24: 1448-53.
54. Smith AG, Ramachandran P, Tripp S, Singleton JR. Epidermal nerve innervation in impaired glucose tolerance and diabetes-associated neuropathy. Neurology 2001; 57: 1701-4.
55. Snider WD. Functions of the neurotrophins during nervous system development: what the knockouts are teaching us. Cell 1994; 77: 627-38.
56. Sumner CJ, Sheth S, Griffin JW, Cornblath DR, Polydefkis M. The spectrum of neuropathy in diabetes and impaired glucose tolerance. Neurology 2003; 60: 108-11.
57. Thomas PK, Tomlinson DR. Diabetic and hypoglycemic neuropathy. In: Dyck PJ, Thomas PK, Griffin JW, Low PA, Poduslo JF, editors. Peripheral neuropathy. 3rd edn. Philadelphia: W.B. Saunders; 1993. p. 1219-50.
58. Wilson PO, Barber PC, Hamid QA, Power BF, Dhillon AP, Rode J, et al. The immunolocalization of protein gene product 9.5 using rabbit polyclonal and mouse monoclonal antibodies. Br J Exp Pathol 1988; 69: 91-104.
59. Woolf CJ, Reynolds ML, Molander C, O'Brien C, Lindsay RM, Benowitz LI. The growth-associated protein GAP-43 appears in dorsal root ganglion cells and in the dorsal horn of the rat spinal cord following peripheral nerve injury. Neuroscience 1990; 34: 465-78.
60. Yarnitsky D. Quantitative sensory testing. Muscle Nerve 1997; 20: 198-204.
61. Yarnitsky D, Ochoa JL. Warm and cold specific somatosensory systems. Psychophysical thresholds, reaction times and peripheral conduction velocities. Brain 1991; 114: 1819-26.
62. Yarnitsky D, Sprecher E. Thermal testing: normative data and repeatability for various test algorithms. J Neurol Sci 1994; 125: 39-45.
63. Yasuda H, Hirai A, Joko M, Terada M, Kawabata T, Maeda K, et al. Effect of aldose reductase inhibitor on cutaneous nerve fiber length in diabetic patients. Diabetes Care 2000; 23: 705.
64. Ziegler D, Mayer P, Muhlen H, Gries FA. The natural history of somatosensory and autonomic nerve dysfunction in relation to glycaemic control during the first 5 years after diagnosis of type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1991; 34: 822-9.